Pharmaceutical Power: $75M in Series C Beckons Two Major Players
TLDR: – Accent Therapeutics has raised $75 million in a series C funding round, with participation from Bristol Myers Squibb and Johnson & Johnson’s investment arm, JJDC. – The funding will help